Lataa...
Severe pneumococcal pneumonia: impact of new quinolones on prognosis
BACKGROUND: Most guidelines have been proposing, for more than 15 years, a β-lactam combined with either a quinolone or a macrolide as empirical, first-line therapy of severe community acquired pneumonia (CAP) requiring ICU admission. Our goal was to evaluate the outcome of patients with severe CAP,...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3065411/ https://ncbi.nlm.nih.gov/pubmed/21406091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-11-66 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|